0 Comments
0 Shares
1K Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Cancer Gene Therapy Market Adoption Rising in Oncology ResearchThe global oncology landscape is undergoing a rapid transformation driven by advances in the cancer immunotherapy market, breakthroughs in gene editing cancer treatment, and the rising adoption of personalized cancer therapy. These innovations are reshaping how cancer is diagnosed, targeted, and treated, shifting the focus from conventional one-size-fits-all approaches to highly precise,...0 Comments 0 Shares 260 Views 0 Reviews
-
Hemato Oncology Testing Market Research: Key Trends & Growth Opportunities"Hemato Oncology Testing Market Summary According to the latest report published by Data Bridge Market Research, the Hemato Oncology Testing Market The global hemato oncology testing market was valued at USD 8.13 billion in 2024 and is expected to reach USD 14.83 billion by 2032 Hemato Oncology Testing Market report is a great option to achieve current as well...0 Comments 0 Shares 224 Views 0 Reviews
-
Histone Deacetylase Inhibitors Market Advances with Expanding Epigenetic Research and Development of Targeted Oncology TherapiesAccording to the latest report published by Data Bridge Market Research, the Histone Deacetylase Inhibitors Market The Global Histone Deacetylase Inhibitors Market was valued at USD 1.3 billion in 2024 and is expected to reach USD 2.3 billion by 2032, at a CAGR of 7.7% during the forecast period The reliable Histone Deacetylase Inhibitors Market report is generated by considering...0 Comments 0 Shares 380 Views 0 Reviews
-
Histone Deacetylase Inhibitors Market Advances with Growing Epigenetic Research and Targeted Oncology TherapiesAccording to the latest report published by Data Bridge Market Research, the Histone Deacetylase Inhibitors Market The Global Histone Deacetylase Inhibitors Market was valued at USD 1.3 billion in 2024 and is expected to reach USD 2.3 billion by 2032, at a CAGR of 7.7% during the forecast period The reliable Histone Deacetylase Inhibitors Market research report includes a...0 Comments 0 Shares 263 Views 0 Reviews
-
United States Carcinoid Syndrome Management Market Forecast Strengthened by Growing Oncology Research InvestmentsThe United States Carcinoid Syndrome Management Market is experiencing steady growth due to the increasing prevalence of neuroendocrine tumors, growing awareness of rare cancers, and continuous advancements in oncology treatment options. The country's advanced healthcare infrastructure, strong pharmaceutical research ecosystem, and widespread adoption of innovative diagnostic and therapeutic...0 Comments 0 Shares 230 Views 0 Reviews
-
VEGF Inhibitors for Cancer Market Growing at 7.3% CAGR Amid Rising Targeted Oncology TherapiesAccording to a new report from Intel Market Research, the global VEGF Inhibitors for Cancer market was valued at USD 8.42 billion in 2025 and is projected to reach USD 15.67 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2026–2034). This growth trajectory reflects the increasing adoption of targeted therapies in oncology and significant advancements in angiogenesis...0 Comments 0 Shares 9K Views 0 Reviews
-
Accelerating Cancer Research: Patient Derived Xenograft Model Market Opportunities, Size & Forecast 2031The Patient‑Derived Xenograft Model Market is becoming a critical pillar in oncology research and drug discovery as global demand for predictive preclinical platforms continues to rise. According to the latest market intelligence, the Patient‑Derived Xenograft Model Market was valued at US$ 468.75 million in 2024 and is projected to reach US$ 1,119.36 million by 2031, reflecting a compound...0 Comments 0 Shares 2K Views 0 Reviews
-
All Trans Retinoic Acid Market to Reach USD 780 Million by 2034 | CAGR 4.7%According to a newly published market research report by 24LifeSciences, global all trans retinoic acid market was valued at USD 520 million in 2025 and is projected to reach USD 780 million by 2034, growing at a compound annual growth rate (CAGR) of 4.7% during the forecast period 2026–2034. All Trans Retinoic Acid (ATRA), chemically known as tretinoin, is a derivative of vitamin A...0 Comments 0 Shares 4K Views 0 Reviews
-
Basal Cell Carcinoma Therapeutics Market to Reach USD 14.6 Billion by 2032 | CAGR 7.3%According to a newly published market research report by 24LifeSciences, global basal cell carcinoma therapeutics market was valued at USD 8.2 billion in 2024 and is projected to reach USD 14.6 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 2025-2032. Basal Cell Carcinoma (BCC), the most common form of skin cancer accounting for...0 Comments 0 Shares 5K Views 0 Reviews
-
Carfilzomib Market Expands with 7.5% CAGR Driven by Advances in Multiple Myeloma TherapiesAccording to a new report from Intel Market Research, the global Carfilzomib market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.89 billion by 2034, growing at a steady CAGR of 7.5% during the forecast period (2025–2034). This growth reflects the expanding clinical application of Carfilzomib in treating relapsed/refractory multiple myeloma, coupled with rising...0 Comments 0 Shares 4K Views 0 Reviews1
-
GVHD Treatment Market to Reach USD 2.1 Billion by 2031 | CAGR 8.5%According to a newly published market research report by 24LifeSciences, global Graft Versus Host Disease (GVHD) Treatment market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.5% during the forecast period 20252031. Graft versus Host Disease, a serious complication following stem cell or bone...0 Comments 0 Shares 2K Views 0 Reviews
-
North America Leads Clinical Trials Market With 50.7% Revenue ShareThe clinical trials market is witnessing strong momentum as pharmaceutical and biotechnology companies continue to increase investments in research and development to accelerate the discovery of advanced therapies. The global clinical trials market size was estimated at USD 89.0 billion in 2025 and is projected to reach USD 158.4 billion by 2033, growing at a CAGR of 7.7% from 2026 to 2033. The...0 Comments 0 Shares 675 Views 0 Reviews
-
Paraneoplastic Syndrome Market Projected to Reach USD 863.73 Million by 2033Paraneoplastic Syndrome Market Overview The global paraneoplastic syndrome market size was valued at USD 511.24 million in 2024 and is anticipated to grow from USD 541.91 million in 2025 to reach USD 863.73 million in 2033, growing at a CAGR of 6% during the forecast period (2025–2033). Download Exclusive Research Report PDF Sample: (Including Full TOC,...0 Comments 0 Shares 4K Views 0 Reviews
-
Sarcoma Drugs Market Forecast 2025–2031: Opportunities in Rare Cancer TherapiesThe rising demand for innovative cancer therapies is fueling the Sarcoma Drugs Market globally. Researchers are focusing on immunotherapy and combination therapies to improve treatment effectiveness. Such developments are strengthening the oncology drug pipeline. The Sarcoma Drugs Market is expected to register a CAGR of 7.9% from 2025 to 2031, with the market size expanding from US$ XX million...0 Comments 0 Shares 8K Views 0 Reviews
-
Tumor Mice Model Market Size to Reach USD 2.92 Billion by 2031 at 7.1% CAGR: Key Players, Growth Trends, and Forecast InsightsTumor mice model market is witnessing sustained growth as oncology research intensifies and pharmaceutical companies seek more predictive preclinical platforms. Valued at USD 1.82 billion in 2024, the market is projected to reach USD 2.92 billion by 2031, expanding at a compound annual growth rate (CAGR) of 7.1% during the forecast period from 2025 to 2032. Discover Market Highlights –...0 Comments 0 Shares 1K Views 0 Reviews
-
[ Latest Report ] Non-Oncology Precision Medicine Market Share, Growth by Business Developments 2025 to 2032Non-Oncology Precision Medicine Market Summary “The global Non-Oncology Precision Medicine Market is expected to reach to USD 57.3 billion by 2032, growing at a CAGR of 5.7% during 2025 to 2032” The TrendBridge Insights Research report, “Global Non-Oncology Precision Medicine Market Report 2025 – Future Opportunities, Latest Trends, In-depth Analysis, and Forecast...0 Comments 0 Shares 1K Views 0 Reviews
More Results